Diabetic retinopathy affects nearly all young patients with type 1 diabetes

Article

One in three young Danish patients with type 1 diabetes mellitus progressed to proliferative diabetic retinopathy, and two in three had 2-step progression despite their young age, according to study results recently published in the November 2013 issue of Acta Diabetologica. In addition, these researchers from Denmark found that after 30-years? duration of diabetes, the presence of diabetic retinopathy was almost universal.

One in three young Danish patients with type 1 diabetes mellitus progressed to proliferative diabetic retinopathy, and two in three had 2-step progression despite their young age, according to study results recently published in Acta Diabetologica. In addition, these researchers from Denmark found that after 30-years' duration of diabetes, the presence of diabetic retinopathy was almost universal.

From 1987 to 1989, these researchers identified a paediatric cohort of children that included approximately 75% of all children in Denmark with type 1 diabetes

In 1995, mean patient age was 21.0 years, and mean duration of diabetes was 13.5 years. The 16-year incidence of proliferative retinopathy was 31.0%, 2-step progression was 64.4% and 2-step regression of diabetic retinopathy was 0.0%. The incidence of diabetic retinopathy was 95.1%.

Upon multivariate logistic regression modelling, progression to proliferative diabetic retinopathy was significantly associated with HbA1c levels in 1995 (OR: 2.61 per 1% increase, 95% CI: 1.85-3.68) and diastolic BP of 1995 (OR: 1.79 per 10 mmHg increase, 95% CI: 1.04-3.07). Two-step progression of diabetic retinopathy was associated with male gender (OR: 2.37 versus female, 95% CI: 1.07-5.27), 1995 HbA1c (OR: 3.02per 1% increase, 95% CI: 2.04-4.48), and 1995 vibration perception threshold (OR: 1.19 per 1 volt increase, 95% CI: 1.02-1.40).

To access these data, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.